G9272 (HCPCS) Reimbursement & Benchmarks

HCPCS Level II code G9272 denotes an LDL (low-density lipoprotein) value of 100 mg/dL or greater recorded from a lipid test. As a nationally recognized reporting code, G9272 is used to document a clinically meaningful cholesterol threshold that can inform cardiovascular risk management, quality measurement, and payer reporting. The code matters nationally because LDL thresholds are commonly referenced in performance measures and care management programs across insurers and public payers.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what the code represents, how it is used in laboratory result reporting, and the clinical context for an LDL at or above 100 mg/dL. The publication summarizes typical sites of service and outlines what stakeholders commonly monitor when this code is recorded.

This analysis offers benchmarks and policy-relevant context to support billing and quality reporting workflows, clarifies the service line and clinical implications tied to an elevated LDL result, and identifies gaps where additional coding or documentation may be required. Data not available in the input are noted where applicable.

Billing Code Overview

HCPCS Level II code G9272 indicates LDL value >= 100. This code denotes a laboratory threshold finding for low-density lipoprotein cholesterol (LDL) equal to or exceeding 100 mg/dL.

Service type: Laboratory result reporting for lipid panel interpretation
Typical site of service: Outpatient laboratory or ambulatory clinic where lipid testing and reporting occur

Data not available in the input.

Clinical Context

A typical patient is a 58-year-old adult attending an outpatient primary care or cardiology visit for risk factor management. The clinician reviews recent laboratory results showing fasting lipid panel values and documents an LDL-C value of 100 mg/dL or greater. The workflow includes verification of the lab result in the electronic health record, clinical assessment of cardiovascular risk (history of coronary artery disease, diabetes, smoking, hypertension), medication reconciliation (statin use, dose, adherence), and counseling regarding lipid-lowering therapy and lifestyle modification. Laboratory testing is commonly performed in the ambulatory clinic’s lab or an external commercial laboratory; results are transmitted to the provider and used to justify clinical decision-making and quality reporting.

Coding Specifications

Modifier	Description	When to Use
`25`	Significant, separately identifiable evaluation and management service by the same physician on the day of a procedure	Use when an E/M visit is distinct from the encounter documenting the LDL result and management plan
`26`	Professional component	Use when reporting only the professional interpretation component of a lab or test (if applicable in combined billing scenarios)

Taxonomy Code	Specialty	Notes
`208000000X`	Family Medicine	Primary care clinicians commonly manage lipid results and risk reduction
`207RC0000X`	Internal Medicine	Internists typically evaluate cardiovascular risk and adjust lipid-lowering therapy
`207L00000X`	Cardiology	Cardiologists manage complex dyslipidemia and high-risk patients
`2086S0122X`	Nurse Practitioner	NPs in ambulatory settings frequently review lab results and manage therapy
`363LP0800X`	Clinical Laboratory Director	Laboratory physicians/directors oversee result reporting and validation

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`E78.00`	Pure hypercholesterolemia, unspecified	Common diagnosis when LDL-C is elevated (>=100 mg/dL) and guides lipid-lowering therapy
`E78.5`	Hyperlipidemia, unspecified	General code used when dyslipidemia is documented but subtype is not specified
`E78.2`	Mixed hyperlipidemia	Relevant when both LDL and triglycerides or other lipids are abnormal alongside LDL >=100 mg/dL
`I10`	Essential (primary) hypertension	Frequently coexists with elevated LDL and influences cardiovascular risk stratification
`E11.9`	Type 2 diabetes mellitus without complications	Diabetes increases ASCVD risk and affects LDL treatment thresholds and intensity
`I25.10`	Atherosclerotic heart disease of native coronary artery without angina pectoris	History of coronary artery disease raises the priority for LDL reduction and is clinically relevant when LDL >=100 mg/dL
`F17.210`	Nicotine dependence, cigarettes, uncomplicated	Active smoking status contributes to cardiovascular risk assessment and management decisions

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`80061`	Lipid panel (includes total cholesterol, HDL, and triglycerides; often includes calculated LDL)	Performed as the laboratory test that yields LDL-C values; typically ordered before or with the visit documenting `G9272`
`84478`	Lipoprotein, direct measurement (LDL-C)	Direct LDL measurement that produces the LDL value reported as >=100 mg/dL; may be used when calculation is unreliable
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Common E/M level for follow-up visits where LDL results are reviewed and management decisions are made
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance)	Used if injectable lipid-lowering therapies (e.g., PCSK9 inhibitors) are administered during the visit following LDL documentation
`99457`	Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified healthcare professional time in a calendar month	May be used when lipid management and counseling are delivered via remote monitoring or telehealth care management following elevated LDL documentation

OpenPayer

Summary & Overview

HCPCS G9272: LDL Value ≥ 100 mg/dL